Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
August 17, 1999

Bausch & Lomb Pharmaceuticals Recalls Erythromycin Ophthalmic Ointment

Tampa, FL (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Bausch & Lomb Pharmaceuticals is recalling Erythromycin Ophthalmic Ointment because of a product mix-up.  Correctly labeled Muro 128Æ Ointment tube (sodium chloride 5%) was found in a carton of erythromycin product.

PRODUCT
Erythromycin Ophthalmic Ointment, USP, 0.5%, Rx, in 3.5 g tubes.

Recall #D-299-9.

CODE
Lot #065151 EXP 5/00.

MANUFACTURER
Bausch & Lomb Pharmaceuticals, Inc., Tampa, Florida.

RECALLED BY
Manufacturer, by letter mailed on July 22, 1999, followed by letter and telephone. Firm-initiated recall ongoing.

DISTRIBUTION
Nationwide.

QUANTITY
49,968 units were distributed.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.